{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T20:00:03Z","timestamp":1774987203979,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003569","name":"Ministry of Food and Drug Safety","doi-asserted-by":"publisher","award":["RS-2023-00216446"],"award-info":[{"award-number":["RS-2023-00216446"]}],"id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003569","name":"Ministry of Food and Drug Safety","doi-asserted-by":"publisher","award":["RS-2024-00331810"],"award-info":[{"award-number":["RS-2024-00331810"]}],"id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer J."],"DOI":"10.1038\/s41408-026-01475-1","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T08:18:33Z","timestamp":1774945113000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and multinational validation of a multiple myeloma\u2013specific comorbidity index using real-world cohorts: CAREMM-2108"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5438-7819","authenticated-orcid":false,"given":"Suein","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1780-5553","authenticated-orcid":false,"given":"Ja Min","family":"Byun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si Eun","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinseon","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seungpil","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seunghoon","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8472-7041","authenticated-orcid":false,"given":"Seung-Hwan","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Ah","family":"Yahng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3362-8200","authenticated-orcid":false,"given":"Young-Woo","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8826-4136","authenticated-orcid":false,"given":"Sung-Soo","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0300-378X","authenticated-orcid":false,"given":"Kazuhito","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Ki","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Catholic Research Network for Multiple Myeloma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"1475_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4065\/78.1.21","volume":"78","author":"RA Kyle","year":"2003","unstructured":"Kyle RA, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Dispenzieri A, et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc. 2003;78:21\u201333.","journal-title":"Mayo Clin Proc"},{"key":"1475_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-52720-1","volume":"14","author":"S Choi","year":"2024","unstructured":"Choi S, Kim E, Jung J, Park SS, Min CK, Han S. Quantitative risk factor analysis of prior disease condition and socioeconomic status with the multiple myeloma development: nationwide cohort study. Sci Rep. 2024;14:4885.","journal-title":"Sci Rep"},{"key":"1475_CR3","doi-asserted-by":"crossref","unstructured":"Bonello F, Grasso M, D\u2019Agostino M, Celeghini I, Castellino A, Boccadoro M, et al. The role of monoclonal antibodies in the first-line treatment of transplant-ineligible patients with newly diagnosed multiple myeloma. Pharmaceuticals. 2020;14:20.","DOI":"10.3390\/ph14010020"},{"key":"1475_CR4","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1038\/s41375-020-0918-6","volume":"34","author":"G Cook","year":"2020","unstructured":"Cook G, Larocca A, Facon T, Zweegman S, Engelhardt M. Defining the vulnerable patient with myeloma-a frailty position paper of the European Myeloma Network. Leukemia. 2020;34:2285\u201394.","journal-title":"Leukemia"},{"key":"1475_CR5","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1182\/blood-2014-12-615187","volume":"125","author":"A Palumbo","year":"2015","unstructured":"Palumbo A, Bringhen S, Mateos MV, Larocca A, Facon T, Kumar SK, et al. Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report. Blood. 2015;125:2068\u201374.","journal-title":"Blood"},{"key":"1475_CR6","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373\u201383.","journal-title":"J Chronic Dis"},{"key":"1475_CR7","doi-asserted-by":"publisher","first-page":"910","DOI":"10.3324\/haematol.2016.162693","volume":"102","author":"M Engelhardt","year":"2017","unstructured":"Engelhardt M, Domm AS, Dold SM, Ihorst G, Reinhardt H, Zober A, et al. A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients. Haematologica. 2017;102:910\u201321.","journal-title":"Haematologica"},{"key":"1475_CR8","doi-asserted-by":"publisher","first-page":"184","DOI":"10.5045\/br.2021.2021107","volume":"56","author":"SS Park","year":"2021","unstructured":"Park SS, Kim HJ, Kim TY, Lee JY, Lee JH, Min GJ, et al. Development and validation of a comorbidity index for predicting survival outcomes after allogeneic stem cell transplantation in adult patients with acute leukemia: a Korean nationwide cohort study. Blood Res. 2021;56:184\u201396.","journal-title":"Blood Res"},{"key":"1475_CR9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13045-024-01569-y","volume":"17","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Liang X, Xu W, Yi X, Hu R, Ma X, et al. Individualized dynamic frailty-tailored therapy (DynaFiT) in elderly patients with newly diagnosed multiple myeloma: a prospective study. J Hematol Oncol. 2024;17:48.","journal-title":"J Hematol Oncol"},{"key":"1475_CR10","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1182\/blood.2024025868","volume":"145","author":"F Smits","year":"2025","unstructured":"Smits F, Groen K, Levin MD, Stege CAM, van Kampen R, van der Spek E, et al. Beyond static measurements: dynamic frailty improves survival prediction in multiple myeloma. Blood. 2025;145:543\u20136.","journal-title":"Blood"},{"key":"1475_CR11","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.1200\/JCO.21.02614","volume":"40","author":"M D\u2019Agostino","year":"2022","unstructured":"D\u2019Agostino M, Cairns DA, Lahuerta JJ, Wester R, Bertsch U, Waage A, et al. Second Revision of the International Staging System (R2-ISS) for overall survival in multiple myeloma: a European Myeloma Network (EMN) Report within the HARMONY Project. J Clin Oncol. 2022;40:3406\u201318.","journal-title":"J Clin Oncol"},{"key":"1475_CR12","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1080\/19371910903070333","volume":"25","author":"DS Kim","year":"2010","unstructured":"Kim DS. Introduction: health of the health care system in Korea. Soc Work Public Health. 2010;25:127\u201341.","journal-title":"Soc Work Public Health"},{"key":"1475_CR13","doi-asserted-by":"publisher","first-page":"119","DOI":"10.4078\/jrd.2021.28.3.119","volume":"28","author":"JS Park","year":"2021","unstructured":"Park JS, Lee CH. Clinical study using healthcare claims database. J Rheum Dis. 2021;28:119\u201325.","journal-title":"J Rheum Dis"},{"key":"1475_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-023-00385-w","volume":"7","author":"SS Park","year":"2023","unstructured":"Park SS, Lee JC, Byun JM, Choi G, Kim KH, Lim S, et al. ML-based sequential analysis to assist selection between VMP and RD for newly diagnosed multiple myeloma. npj Precis Oncol. 2023;7:46.","journal-title":"npj Precis Oncol"},{"key":"1475_CR15","doi-asserted-by":"crossref","unstructured":"Park SS, Shin SH, Lee JY, Jeon YW, Yhang SA, Min CK. Prospective comparative study of etoposide plus G-CSF versus G-CSF alone, followed by risk-adapted plerixafor for peripheral blood stem cell mobilization in patients with newly diagnosed multiple myeloma: catholic research network for Multiple Myeloma Study (CAREMM-2001). Cancers. 2023;15:4783.","DOI":"10.3390\/cancers15194783"},{"key":"1475_CR16","doi-asserted-by":"publisher","first-page":"74.e1","DOI":"10.1016\/j.jtct.2024.11.010","volume":"31","author":"S Choi","year":"2025","unstructured":"Choi S, Byun JM, Park SS, Han J, Oh S, Jung S, et al. Efficacy and safety of bispecific T-cell engagers in relapsed\/refractory multiple myeloma: a real-world data-based case-controlled study. Transplant Cell Ther. 2025;31:74.e1\u2013e11.","journal-title":"Transplant Cell Ther"},{"key":"1475_CR17","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s44313-025-00069-3","volume":"60","author":"SS Park","year":"2025","unstructured":"Park SS, Park Y, Yoon S, Lee D, Jeong J, Kim K. Real-world treatment patterns, outcomes, and economic costs by lines of therapy in patients with newly diagnosed multiple myeloma: a nationwide population-based cohort study in South Korea. Blood Res. 2025;60:26.","journal-title":"Blood Res"},{"key":"1475_CR18","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0895-4356(01)00521-2","volume":"55","author":"P Halfon","year":"2002","unstructured":"Halfon P, Eggli Y, van Melle G, Chevalier J, Wasserfallen JB, Burnand B. Measuring potentially avoidable hospital readmissions. J Clin Epidemiol. 2002;55:573\u201387.","journal-title":"J Clin Epidemiol"},{"key":"1475_CR19","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.jclinepi.2004.03.012","volume":"57","author":"V Sundararajan","year":"2004","unstructured":"Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, Ghali WA. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol. 2004;57:1288\u201394.","journal-title":"J Clin Epidemiol"},{"key":"1475_CR20","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","volume":"43","author":"H Quan","year":"2005","unstructured":"Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43:1130\u20139.","journal-title":"Med Care"},{"key":"1475_CR21","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1002\/sim.5958","volume":"32","author":"P Blanche","year":"2013","unstructured":"Blanche P, Dartigues JF, Jacqmin-Gadda H. Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks. Stat Med. 2013;32:5381\u201397.","journal-title":"Stat Med"},{"key":"1475_CR22","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/aje\/kwq433","volume":"173","author":"H Quan","year":"2011","unstructured":"Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173:676\u201382.","journal-title":"Am J Epidemiol"},{"key":"1475_CR23","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jclinepi.2022.03.022","volume":"148","author":"A Drosdowsky","year":"2022","unstructured":"Drosdowsky A, Gough K. The Charlson Comorbidity Index: problems with use in epidemiological research. J Clin Epidemiol. 2022;148:174\u20137.","journal-title":"J Clin Epidemiol"},{"key":"1475_CR24","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.5045\/br.2020.S007","volume":"55","author":"SH Jung","year":"2020","unstructured":"Jung SH, Jo JC, Song GY, Ahn SY, Yang DH, Ahn JS, et al. Frontline therapy for newly diagnosed patients with multiple myeloma. Blood Res. 2020;55:S37\u2013s42.","journal-title":"Blood Res"},{"key":"1475_CR25","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.5045\/br.2020.S008","volume":"55","author":"JH Lee","year":"2020","unstructured":"Lee JH, Kim SH. Treatment of relapsed and refractory multiple myeloma. Blood Res. 2020;55:S43\u2013s53.","journal-title":"Blood Res"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01475-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01475-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01475-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T19:16:08Z","timestamp":1774984568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01475-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1475"],"URL":"https:\/\/doi.org\/10.1038\/s41408-026-01475-1","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"26 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted according to the ethical guidelines of the Declaration of Helsinki with approval by the Institutional Review Board of Seoul St. Mary\u2019s Hospital, Seoul, Korea \/ Seoul National University Hospital \/ The Jikei University School of Medicine. Informed consent was waived due to the use of retrospective clinical data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"52"}}